← All companies

Celltrion

Healthcare & Life Sci

Company overview

Celltrion is a biopharmaceutical company that researches, develops, manufactures and distributes biosimilar medications. Remsima, an infliximab biosimilar, treats rheumatoid arthritis, Crohn's disease, ulcerative colitis and psoriasis. Herzuma, a trastuzumab biosimilar, targets HER2-positive breast and stomach cancers. Truxima, a rituximab biosimilar, addresses rheumatoid arthritis and lymphomas. Celltrion is headquartered in Yeonsu-gu, Incheon, South Korea.

Celltrion was established in 2002. Its biosimilar business has grown into three separate drug franchises for arthritis, cancer and immune disease, run by a company of about 2,995 people.

Currently, there are no job openings at Celltrion. Over the last 30 days, 0 jobs were added and 0 were removed. Celltrion is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
Incheon, South Korea

Filters

Create your account

Create an account to save jobs and track applications.